Combining epidemiology with basic biology of sand flies, parasites, and hosts to inform leishmaniasis transmission dynamics and control
Novel line of research is Leishmaniasis revealing that time can play a large role in host-parasite dynamics and affect severity of Leishmania infections.
A free course on post-kala-azar dermal leishmaniasis (PKDL) is now accessible through the free online eLearning Platform of the World Health Organization (WHO). This course on PKDL is part of a new e-learning initiative devoted to sustainable control of neglected tropical diseases.
Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage
New study suggesting Leishmania parasites are capable of entering a quiescent state for up to seven days or longer.
Trend in cumulative cases and mortality rate among visceral leishmaniasis patients in Eastern Sudan: a 14-year registry, 2002–2015
A retrospective descriptive study with data from a 14-year study period (2002–2015) investigating the cumulative number of cases, case fatality rate, and trend in incidence and mortality rate of visceral leishmaniasis (VL) in Eastern Sudan.
Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent – A Systematic Literature Review
Systematic review aiming at uncovering the role of asymptomatic Leishmania infection (ALI), PKDL and VL relapse in transmission in the Indian subcontinent, particulalry upon approaching VL elimination .
A manual for health workers aiming to guide early recognition of PKDL.
Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent
Important xenodiagnosis study revealing the infectivity of PKDL patients.
Oral presentation delivered at the 6th World Congress for Leishmaniasis 16-20 May 2017, Toledo, Spain. Title: Cross-sectional surveys in Bangladesh, Nepal, Ethiopia and Sudan: Understanding treatment seeking and household economic burden for VL patients.